首页> 美国卫生研究院文献>other >Analogs of JHU75528 a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity
【2h】

Analogs of JHU75528 a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity

机译:JHU75528的类似物一种用于脑大麻素受体(CB1)成像的PET配体:开发具有最佳亲脂性和结合亲和力的配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cyano analogs of Rimonabant with high binding affinity for the cerebral cannabinoid receptor (CB1) and with optimized lipophilicity have been synthesized as potential positron emission tomography (PET) ligands. The best ligands of the series are optimal targets for the future radiolabeling with PET isotopes and in vivo evaluation as radioligands with enhanced properties for PET imaging of CB1 receptors in human subjects. Extracellular electrophysiological recordings in rodent brain slices demonstrated that JHU75528, >4, the lead compound of the new series, has functional CB antagonist properties that are consistent with its structural relationship to Rimonabant. Molecular modeling analysis revealed an important role of the binding of the cyano-group with the CB1 binding pocket.
机译:利莫那班对脑大麻素受体(CB1)具有高结合亲和力和优化的亲脂性的氰基类似物已被合成为潜在的正电子发射断层扫描(PET)配体。该系列的最佳配体是未来用PET同位素进行放射性标记和体内评估的最佳靶标,因为放射性配体具有增强的特性,可用于人类受试者CB1受体的PET成像。啮齿动物脑切片的细胞外电生理记录表明,新系列的先导化合物JHU75528 > 4 具有功能性CB拮抗剂特性,与其与Rimonabant的结构关系一致。分子模型分析揭示了氰基与CB1结合口袋的结合的重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号